Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 14 April 2027
- Last conf. stmt
- 31 March 2026
Istesso Therapeutics Limited
- Incorporated
- 5 April 2005 (21 years)
- Previously known as
- Modern Biosciences Limited (until 1 November 2024)Modern Biosciences PLC (until 14 June 2017)Modern Biosciences Limited (until 6 March 2006)Earlier: Lifeuk (Ip2ipo) Limited, Pimco 2288 Limited
- Industry
- Other research and experimental development on natural sciences and engineering (72190)
- Directors
- Owned by
- Accounts type
- Total exemption full
- Region
- Greater London
- Address
- 2nd Floor 3 Pancras SquareKings CrossLondonN1C 4AG
Officers 3 active
Officer details are public data from the Companies House register.
Director · Appointed 27 January 2022
British
Born May 1973 (53)
Corporate Secretary · Appointed 12 September 2017
Director · Appointed 2 April 2007
British
Born April 1969 (57)
Officer history (16 former)
27 January 2022
27 January 2022
3 October 2017
Resigned Patel, Lisa, Dr as Director
12 September 2017
12 September 2017
2 July 2014
26 September 2013
Appointed Patel, Lisa, Dr as Director
23 November 2012
Resigned Patel, Lisa, Dr as Director
14 December 2011
Appointed Patel, Lisa, Dr as Director
25 January 2011
Resigned Dix, Clive James, Dr as Director
27 May 2010
2 June 2009
2 June 2009
2 June 2009
2 June 2009
2 June 2009
8 February 2008
Resigned Stevenson, Alexander James, Dr as Director
8 January 2008
8 January 2008
8 January 2008
8 January 2008
3 September 2007
Appointed Dix, Clive James, Dr as Director
2 April 2007
31 July 2006
8 June 2006
Appointed Stevenson, Alexander James, Dr as Director
13 March 2006
17 June 2005
17 June 2005
17 June 2005
17 June 2005
17 June 2005
17 June 2005
17 June 2005
5 April 2005
5 April 2005
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 13 November 2017
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Limited By Shares
Reg. no. 10756496
Holdings 3
Companies where Istesso Therapeutics Limited is registered as a person with significant control
Owns 75–100% of shares
Active
Owns 75–100% of shares
Active
Owns 75–100% of shares
Active
Former controllers (1)
13 November 2017
Ceased IP Group PLC — Owns 50–75% of shares
Group structure 58 shown
Ownership group derived from the Companies House PSC register
Fusion IP Cardiff Limited Owns 75–100% of shares
Fusion IP Sheffield Limited Owns 75–100% of shares
Ip2ipo Carry Partner Limited Owns 75–100% of shares
Ip2ipo Investments Limited Owns 75–100% of shares
Ip2ipo Limited Owns 75–100% of shares
Alesi Surgical Limited Owns 25–50% of shares
Boxarr Limited Owns 25–50% of shares
IP Venture Fund (FP) Limited Partnership Part right to 25–50% of surplus assets
Ip2ipo Americas Limited Owns 75–100% of shares
Ip2ipo Anz Carry Limited Owns 75–100% of shares
Ipg Usa (LP) Limited Owns 75–100% of shares
Istesso Limited Owns 25–50% of shares
Istesso 2 Limited Owns 75–100% of shares
Istesso 3 Limited Owns 75–100% of shares
Istesso Therapeutics Limited This company Owns 75–100% of shares
MBS5 Limited Owns 75–100% of shares
PH Therapeutics Limited Owns 50–75% of shares
Ip2ipo Nominees Limited Owns 75–100% of shares
Ip2ipo Services Limited Owns 75–100% of shares
Magnomatics Limited Owns 25–50% of shares
Parkwalk Advisors Ltd Owns 75–100% of shares
Ikarovec Limited Owns 25–50% of shares
Lettus Grow Ltd Owns 25–50% of shares
Mind Foundry Limited Holds 25–50% of voting rights
Moa Technology Limited Owns 25–50% of shares
Opsydia Limited Has significant influence or control
Oxford Endovascular Limited Holds 25–50% of voting rights
Pervasid Limited Owns 25–50% of shares
Psyomics Ltd Owns 50–75% of shares
Salunda Limited Holds 25–50% of voting rights
Symetrica Limited Has significant influence or control
Symetrica Security Ltd Owns 75–100% of shares
Top Technology Ventures Limited Owns 75–100% of shares
IP Capital Limited Owns 75–100% of shares
IP Venture Fund II (GP) LLP Right to 75–100% of surplus assets
IP Ventures (Scotland) Limited Owns 75–100% of shares
Ip2ipo Portfolio (GP) Limited Owns 75–100% of shares
Accelercomm Ltd Owns 25–50% of shares
Audioscenic Limited Owns 25–50% of shares
Barocal Ltd Owns 25–50% of shares
First Light Fusion Limited Owns 25–50% of shares
Ibex Innovations Ltd Has significant influence or control
Intrinsic Semiconductor Technologies Limited Owns 25–50% of shares
Ionix Advanced Technologies Ltd Owns 25–50% of shares
Kiko Ventures Limited Owns 75–100% of shares
Lumai Limited Owns 25–50% of shares
Mixergy Limited Has significant influence or control
Oxehealth Limited Owns 25–50% of shares
Touchstone Innovations Limited Owns 75–100% of shares
Ip2ipo Innovations Limited Owns 75–100% of shares
Touchstone Innovations Businesses LLP Right to 75–100% of surplus assets
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 8 June 2026 | Total exemption full accounts | 31 December 2025 | ||
| 31 March 2026 | Confirmation statement with no updates | 31 March 2026 | ||
| 15 September 2025 | Total exemption full accounts | 31 December 2024 | ||
| 11 April 2025 | Confirmation statement with no updates | 31 March 2025 | ||
| 3 January 2025 | Total exemption full accounts | 31 December 2023 |
Some other companies at this address
Other companies in this industry
Oxford
Cambridge
Coventry
Weybridge
Stevenage
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →